Xeno Biosciences
Somerville, US · Founded 2015
Biotech
Founders & leadership
MK
Michael KoerisDirector
HC
Hasan CelikerExecutive Officer, Director
DB
David BenoDirector
Reported raises · per SEC filings
Form D private placements$1.5MraisedJan 2023 · 64 investors · Biotechnology
Rule 506(b)$9.4MraisedAug 2021 · 133 investors · Biotechnology
Rule 506(b)$720KraisedFeb 2019 · 21 investors · Biotechnology
Rule 506(b)$450KraisedAug 2018 · 20 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.